Document:

QuickLinks
 -- Click here to rapidly navigate through this document

Exhibit 4.9  

         

  

 
 

SYSTEMS XCELLENCE INC. ANNOUNCES PROPOSED PUBLIC OFFERING
  AND RELATED SHARE CONSOLIDATION    
    

MILTON, Ontario June 6, 2006, Systems Xcellence Inc. ("SXC" or the "Company") (TSX: SXC) today announced that it has filed a preliminary
short-form base PREP prospectus with Canadian securities regulators and a registration statement on Form F-10 with the U.S. Securities and Exchange
Commission (the "SEC") in connection with a proposed public offering of its common shares in Canada and an initial public offering of its common shares in the United States
(collectively, the "Offering"). The Offering will be made to investors in the United States and Canada. In connection with the proposed Offering, the Company has applied to have its common
shares listed on the Nasdaq National Market under the symbol "SXCI". The Company's common shares will also continue to trade on the Toronto Stock Exchange under the symbol "SXC". 

SXC
has also filed articles of amendment to consolidate its common shares on the basis that each four outstanding common shares became one post-consolidation common share. Current holders
of SXC common shares will receive shortly a letter of transmittal instructing them how to receive a new certificate representing the number of post-consolidation common shares to which
they are entitled. 

In
connection with the filing of the preliminary short form prospectus, SXC has amended and re-filed its audited consolidated financial statements for the year ended December 31,
2005 to give effect to the share consolidation and to provide a reconciliation of significant differences between accounting principles generally accepted in Canada and the United States. 

Pursuant
to the Offering, it is currently expected that SXC will sell 3.2 million common shares to raise gross proceeds of approximately US$50 million. SXC also intends to grant the
syndicate of underwriters an option to purchase up to an additional 480,000 common shares within 30 days of the date of the final prospectus to cover over-allotments,
if any. All of the common shares to be sold in the Offering will be newly issued. SXC plans to use the net proceeds from the Offering to retire its existing credit facility with the remainder to be
used for potential acquisitions, working capital and general corporate purposes. 

UBS
Investment Bank will be acting as the sole book running manager for the Offering, and the underwriting syndicate will also include JP Morgan, William Blair & Company, SunTrust Robinson
Humphrey, Sprott Securities, Orion Securities and Clarus Securities. When available, copies of the preliminary prospectus may be obtained from UBS Investment Bank, 299 Park Avenue,
New York, NY 10171 or 161 Bay Street, Suite 4100, Toronto, ON, M5J 2S1. 

A
registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time
the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any
state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. 

About Systems Xcellence  

SXC
is a leading provider of healthcare information technology solutions and services to providers, payors and other participants in the pharmaceutical supply chain in the United States and
Canada. SXC's product offerings include a wide range of pharmacy benefit management services and software products for managing prescription drug programs and for drug prescribing and dispensing. SXC
is headquartered in Milton, Ontario with offices and processing centres in Lombard, Illinois, Scottsdale, Arizona, Warminster, Pennsylvania and Victoria, British Columbia. 

Forward-Looking Statements  

Certain statements included herein, including those that express management's expectations or estimates of future developments or SXC's future performance constitute
"forward-looking statements" within the meaning of applicable securities laws. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered
reasonable by management at this time, are inherently subject to significant business, economic and competitive uncertainties and contingencies. SXC cautions that such forward-looking statements
involve known and unknown risks, uncertainties and other risks that may cause SXC's actual financial results, performance, or achievements to be materially different from its estimated future results,
performance or achievements expressed or implied by those forward-looking statements. Numerous factors could cause actual results to differ materially from those in the forward-looking statements,
including without limitation, SXC's ability to achieve increased market acceptance for its product offerings and penetrate new markets; consolidation in the healthcare industry; the existence of
undetected errors or similar problems in its software products; its ability to identify and complete acquisitions, manage its growth and integrate acquisitions; its ability to compete successfully;
potential liability for the use of incorrect or incomplete data; the length of the sales cycle for its healthcare software solutions; interruption of its operations due to outside sources; its
dependence on key customers; maintaining its intellectual property rights and litigation involving intellectual property rights; its ability to obtain, use or successfully integrate third-party
licensed technology; compliance with existing laws, regulations and industry initiatives and future change in laws or regulations in the healthcare industry; breach of its security by third parties;
its dependence on the expertise of its key personnel; its access to sufficient capital to fund its future requirements; and potential write-offs of goodwill or other intangible assets.
This list is not exhaustive of the factors that may affect any of SXC's forward-looking statements. Investors are cautioned not to put undue reliance on forward-looking statements. All subsequent
written and oral forward-looking statements attributable to SXC or persons acting on its behalf are expressly qualified in their entirety by this notice. SXC disclaims any intent or obligation to
update publicly these forward-looking statements, whether as a result of new information, future events or otherwise. Risks and uncertainties about SXC's business are more fully discussed in its
Annual Information Form.

Certain of the assumptions made by SXC in preparing forward-looking information and management's expectations include: maintenance of its existing customers and future
retention of its contracts, its ability to market its products successfully to anticipated customers, the impact of increasing competition, the growth of prescription drug utilization rates at
predicted levels, the retention of its key personnel, its customers continuing to process transactions at historical levels, that its systems will not be interrupted for any significant period of
time, that its products will continue to perform free of major errors, its ability to obtain financing on acceptable terms and that there will be no significant changes in the regulation of its
business.

Completion of the Offering is subject to market conditions and other factors, and there can be no assurance that the Offering will be completed on the contemplated terms or at
all or that the Company's common shares will be accepted for listing on the Nasdaq National Market.

For more information, please contact:  

	Dave Mason	 	Jeff Park
	Investor Relations — Canada	 	Chief Financial Officer
	The Equicom Group Inc.	 	Systems Xcellence Inc.
	(416) 815-0700 ext. 237	 	Tel: (905) 876-4741
	dmason@equicomgroup.com	 	investors@sxc.com
	
OR	
 	

 
	
 Susan Noonan

Investor Relations — U.S.
 The SAN Group, LLC

(212) 966-3650

susan@sanoonan.com	
 	

 

QuickLinks

SYSTEMS XCELLENCE INC. ANNOUNCES PROPOSED PUBLIC OFFERING AND RELATED SHARE CONSOLIDATIONQuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.2.5    
    

 
 

VERIGY LTD. 2006 EQUITY INCENTIVE PLAN
  NOTICE OF SHARE OPTION GRANT    
    

For Awardees located outside the United States  

        You
have been granted the following option to purchase shares of the Ordinary Shares of Verigy Ltd. (the "Company"): 

	Name of Optionee:	 	«Name»
	

Total Number of Shares:	
 	

«TotalShares»
	

Type of Option:	
 	

«NSO» Nonstatutory Share Option
	

Exercise Price Per Share:	
 	

$«PricePerShare»
	

Date of Grant:	
 	

«DateGrant»
	

Vesting Commencement Date:	
 	

«VestDay»
	

Vesting Schedule:	
 	

This option becomes exercisable with respect to the first «CliffPercent»% of the Shares subject to this option when you complete «CliffPeriod» months of continuous "Service" (as defined in the Plan) as an "Awardee Eligible to
Vest" (as defined in the Plan) from the date of this award. Thereafter, this option becomes exercisable with respect to an additional «Percent»% of the Shares subject to this option on each subsequent anniversary of the award date,
provided that you continue to be an Awardee Eligible to Vest as of such date.
	

Expiration Date:	
 	

«ExpDate». This option may expire earlier if your Service terminates earlier, as described in the Share Option Agreement.

        You
and the Company agree that this option is granted under and governed by the terms and conditions of the Verigy Ltd. 2006 Equity Incentive Plan (the "Plan") and the Share
Option Agreement, both of which are attached to and made a part of this document. 

        You
further agree that the Company may deliver electronically all documents relating to the Plan or this option (including, without limitation, prospectuses required by the Securities
and Exchange Commission) and all other documents that the Company is required to deliver to its security holders (including, without limitation, annual reports and proxy statements). You also agree
that the Company may deliver these documents by posting them on a web site maintained by the Company or by a third party under contract with the Company. If the Company posts these documents on a web
site, it will notify you regarding such posting. 

	OPTIONEE:	 	VERIGY LTD.
	

    
	
 	

By:	
 	

    

	

 	
 	

Title:	
 	

    

 
 

VERIGY LTD. 2006 EQUITY INCENTIVE PLAN
  SHARE OPTION AGREEMENT    
    

 
  For Awardees located outside the United States    
    

	Tax Treatment	 	This option is intended to be a nonstatutory stock option, as provided in the Notice of Share Option Grant.
	
Vesting	
 	

This option becomes exercisable in installments, during the Option term as shown in the Notice of Share Option Grant, as long as you remain an Awardee Eligible to Vest (as defined in the Plan). In addition, this option is subject to certain vesting
acceleration provisions in the event your Service terminates because of retirement, total and permanent disability, or death.
	

 	
 	

Vesting may also be accelerated in connection with a termination without Cause (as defined in the Plan) within 12 months following a Change in Control (as defined in the Plan), or in connection with a corporate reorganization, as provided in the
Plan.
	

 	
 	

This option will in no event become exercisable for additional shares after your Service has terminated for any reason, except as otherwise provided in the Plan and this Share Option Agreement.
	
Term	
 	

This option expires in any event at the close of business at Company headquarters on the day before the 7th anniversary of the Date of Grant, as shown in the Notice of Share Option Grant. (It may expire earlier if your Service terminates,
as described below.)
	
Regular Termination	
 	

If your Service terminates for any reason except death, total and permanent disability, or retirement due to age, in accordance with the Company's or a Subsidiary's or Affiliate's retirement policy, then this option will expire at the close of
business at Company headquarters on the date three months after your termination date, or, if earlier, the expiration of the term of this option. The Company determines when your Service terminates for this purpose.
	
Death	
 	

If you die before your Service terminates, then this option will expire at the close of business at Company headquarters on the date 12 months after the date of death, or, if earlier, the expiration of the term of this option.
	
Disability	
 	

If your Service terminates because of your total and permanent disability, then this option will expire at the close of business at Company headquarters on the date 12 months after your termination date, or, if earlier, the expiration of the
term of this option.
	 	 	 

	

 	
 	

For all purposes under this Share Option Agreement, "total and permanent disability" means that you are unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected
to result in death or which has lasted, or can be expected to last, for a continuous period of not less than one year.
	
Leaves of Absence and Part-Time Work	
 	

For purposes of this option, your Service does not terminate when you go on a military leave, a sick leave or another Company approved leave of absence, and if continued crediting of Service is required by the terms of the leave or by applicable law.
But your Service terminates when the approved leave ends, unless you immediately return to active work.
	

 	
 	

Your status as an Awardee Eligible to Vest (as defined in the Plan) will always cease upon termination of employment with the Company or a Subsidiary or Affiliate except as provided in Article 5 of the Plan.
	

 	
 	

If you commence working on a part-time basis, then the vesting schedule specified in the Notice of Share Option Grant may be adjusted in accordance with the Company's part-time work policy or the terms of an agreement between you and the Company
pertaining to your part-time schedule.
	
Restrictions on Exercise	
 	

The Company will not permit you to exercise this option if the issuance of shares at that time would violate any law or regulation.
	
Notice of Exercise	
 	

You may exercise this option from time to time for any number of shares for which the option is then exercisable, by notice in writing, electronically or by other means to, and as proscribed by, the Company's equity incentive administration service
provider (the "administration service provider"). Your exercise notice will be effective and irrevocable at such time as your notice, method of payment (whether by cash, check, proceeds from the immediate sale of the option shares, or as otherwise
provided in the Plan) and such other documentation as the administration service provider may require have been received by the administration service provider.
	

 	
 	

If someone else wants to exercise this option after your death, that person must prove to the Company's satisfaction that he or she is entitled to do so.
	
Form of Payment	
 	

When you exercise this option, you must provide for payment of the option exercise price for the shares that you are purchasing. To the extent permitted by applicable law, payment may be made in one (or a combination of two or more) of the forms set
forth in Sections 5.7 (a), (c) and (d) of the Plan.
	 	 	 

	
Withholding Taxes and Stock Withholding	
 	

Regardless of any action the Company or your employer (the "Employer") takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related withholding ("Tax-Related Items"), you acknowledge that the
ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in
connection with any aspect of the option grant, including the grant, vesting or exercise of the option, the subsequent sale of shares acquired pursuant to such exercise and the receipt of any dividends; and (2) do not commit to structure the
terms of the grant or any aspect of the option to reduce or eliminate your liability for Tax-Related Items. Prior to exercise of the option, you will pay or make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all
withholding and payment on account obligations of the Company and/or the Employer. In this regard, you authorize the Company and/or the Employer to withhold all applicable Tax-Related Items legally payable by you from your wages or other cash
compensation paid to you by the Company and/or the Employer or from proceeds of the sale of shares. Alternatively, or in addition, if permissible under local law, the Company may (1) sell or arrange for the sale of shares that you acquire to
meet the withholding obligation for Tax-Related Items, and/or (2) withhold in shares, provided that the Company only withholds the amount of shares necessary to satisfy the minimum withholding amount. Finally, you will pay to the Company or the
Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold as a result of your participation in the Plan or your purchase of shares that cannot be satisfied by the means previously described. The Company may
refuse to honor the exercise and refuse to deliver the shares if you fail to comply with your obligations in connection with the Tax-Related Items as described in this section.
	
Restrictions on Resale	
 	

You agree not to sell any option shares at a time when applicable laws, Company policies or an agreement between the Company and its underwriters prohibit a sale. This restriction will apply as long as your Service continues and for such period of
time after the termination of your Service as the Company may specify.
	
Transfer of Option	
 	

This option may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by the beneficiary designation, will or by the laws of descent or distribution and may be exercised, during your lifetime, only by
you.
	
Retention Rights	
 	

Your option or this Share Option Agreement does not give you the right to be retained by the Company or a subsidiary of the Company in any capacity. The Company and its subsidiaries reserve the right to terminate your Service at any time, with or
without cause.
	 	 	 

	
Stockholder Rights	
 	

You, or your estate or heirs, have no rights as a stockholder of the Company until you have exercised this option by submitting the required notice in accordance with the provisions under "Notice of Exercise" set forth above and paying the exercise
price and any applicable withholding taxes. No adjustments are made for dividends or other rights if the applicable record date occurs before you exercise this option, except as described in the Plan.
	
Adjustments	
 	

In the event of a stock split, a stock dividend or a similar change in Company stock, the number of shares covered by this option and the exercise price per share may be adjusted pursuant to the Plan.
	
Nature of the Grant	
 	

In accepting the grant, you acknowledge that:
	

 	
 	

        (a)    the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, unless
otherwise provided in the Plan and this Share Option Agreement;
	

 	
 	

        (b)    the grant of the option is voluntary and occasional and does not create any contractual or other right to receive future grants of options, or benefits in lieu of options,
even if options have been granted repeatedly in the past;
	

 	
 	

        (c)    all decisions with respect to future option grants, if any, will be at the sole discretion of the Company;
	

 	
 	

        (d)    you are voluntarily participating in the Plan;
	

 	
 	

        (e)    the option is an extraordinary item that does not constitute compensation of any kind for services of any kind rendered to the Company or the Employer, and which is outside
the scope of your employment contract, if any;
	

 	
 	

        (f)    the option is not part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any severance, resignation, termination,
redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or the
Employer;
	

 	
 	

        (g)    in the event that you are not an employee of the Company, the option grant will not be interpreted to form an employment contract or relationship with the Company; and
furthermore, the option grant will not be interpreted to form an employment contract with the Employer or any subsidiary or affiliate of the Company;
	

 	
 	

        (h)    the future value of the underlying shares is unknown and cannot be predicted with certainty;
	

 	
 	

        (i)    if the underlying shares do not increase in value, the option will have no value;
	 	 	 

	

 	
 	

        (j)    if you exercise your option and obtain shares, the value of those shares acquired upon exercise may increase or decrease in value, even below the exercise price;
	

 	
 	

        (k)    in consideration of the grant of the option, no claim or entitlement to compensation or damages shall arise from termination of the option or diminution in value of the option
or shares purchased through exercise of the option resulting from termination of your employment by the Company or the Employer (for any reason whatsoever and whether or not in breach of local labor laws) and you irrevocably release the Company and
the Employer from any such claim that may arise; if, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen, then, by signing this Share Option Agreement, you shall be deemed irrevocably to have
waived your entitlement to pursue such claim; and
	

 	
 	

        (l)    in the event of termination of your employment (whether or not in breach of local labor laws), your right to receive the option and vest in the option under the Plan, if any,
will terminate effective as of the date that you are no longer actively employed and will not be extended by any notice period mandated under local law (e.g., active employment would not include a period
of "garden leave" or similar period pursuant to local law); furthermore, in the event of termination of employment (whether or not in breach of local labor laws), your right to exercise the option after termination of employment, if any, will be
measured by the date of termination of your active employment and will not be extended by any notice period mandated under local law; the Company shall have the exclusive discretion to determine when you are no longer actively employed for purposes
of your option grant.
	
Data Privacy Notice and Consent	
 	
You hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Share Option Agreement by and among, as applicable,
your employer, the Company, its subsidiaries and its affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.
	 	 	 

	

 	
 	
You understand that the Company and your employer may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance
number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all options or any other entitlement to shares awarded, canceled, vested, unvested or outstanding in your
favor, for the purpose of implementing, administering and managing the Plan ("Data"). You understand that Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that these recipients
may be located in your country, or elsewhere, and that the recipient's country may have different data privacy laws and protections than your country. You understand that you may request a list with the names and addresses of any potential recipients
of the Data by contacting your local human resources representative. You authorize the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing your
participation in the Plan, including any requisite transfer of such Data as may be required to a broker, escrow agent or other third party with whom the shares received upon exercise of the option may be deposited. You understand that Data will be
held only as long as is necessary to implement, administer and manage your participation in the Plan. You understand that you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary
amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local human resources representative. You understand that refusal or withdrawal of consent may affect your ability to participate in
the Plan. For more information on the consequences of your refusal to consent or withdrawal of consent, You understand that You may contact your local human resources representative.
	
Language	
 	

If you have received this Share Option Agreement or any other document related to the Plan translated into a language other than English and if the translated version is different than the English version, the English version will
control.
	
Applicable Law	
 	

This Share Option Agreement shall be governed by, and construed in accordance with, the laws of the Republic of Singapore (except its choice-of-law provisions).
	
The Plan and Other Agreements	
 	

The text of the Plan is incorporated in this Share Option Agreement by reference.
	

 	
 	

This Share Option Agreement and the Plan constitute the entire understanding between you and the Company regarding this option. Any prior agreements, commitments or negotiations concerning this option are superseded. This Share Option Agreement may
be amended only by another written agreement between the parties.
	 	 	 

	

 	
 	

If one or more of the provisions of this Share Option Agreement shall be held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby
and the invalid, illegal or unenforceable provisions shall be deemed null and void; however, to the extent permissible by law, any provisions which could be deemed null and void shall first be construed, interpreted or revised retroactively to permit
this Share Option Agreement to be construed so as to foster the intent of this Share Option Agreement and the Plan.

YOUR ELECTRONIC SIGNATURE TO THIS NOTICE AND AGREEMENT IS YOUR AGREEMENT TO ALL OF THE TERMS AND CONDITIONS DESCRIBED ABOVE AND IN THE PLAN.

QuickLinks

Exhibit 10.2.5

VERIGY LTD. 2006 EQUITY INCENTIVE PLAN NOTICE OF SHARE OPTION GRANT

VERIGY LTD. 2006 EQUITY INCENTIVE PLAN SHARE OPTION AGREEMENT

For Awardees located outside the United States

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}]]